BD Perisafe™ Tuohy Epidural Needle and BD Perisafe™ Weiss Epidural Needle are indicated for the administration of anesthesia or analgesia into the epidural space, or to introduce a dedicated catheter for continuous administration of anesthesia or analgesia into the epidural space. They can also be used to introduce a spinal needle to perform a combined spinal and epidural procedure. These devices are intended for adult and pediatric patients.
Device Story
Single-use, sterile epidural needles (Tuohy or Weiss tip) used by clinicians to access the epidural space. Device consists of a stainless steel cannula bonded to a polypropylene hub, with a color-coded polypropylene stylet handle and protective shield. Clinician inserts needle into patient's epidural space; needle serves as conduit for anesthetic/analgesic delivery or catheter placement. Weiss tip includes wings on hub for improved manual grip. Device facilitates regional anesthesia administration, potentially benefiting patients by enabling pain management or surgical anesthesia. No electronic or software components.
Clinical Evidence
Bench testing only. No clinical data required. Performance verified via ISO 594-1/-2 (fluid leakage, pressure decay, stress cracking, axial load, unscrewing, overriding), ISO 9626 (stiffness, breakage), ISO 7864 (cannula pull force), and internal testing (stylet/handle/shield separation). Biocompatibility confirmed per ISO 10993-1:2018 (cytotoxicity, sensitization, reactivity, systemic toxicity, pyrogenicity, chemical characterization) and additional testing (hemolysis, LAL endotoxin, particulate matter, neurotoxicity).
Technological Characteristics
Materials: stainless steel cannula, polypropylene hub/shield. Dimensions: 16G-20G, lengths 50.8mm-127mm. Tip geometries: Tuohy, Weiss. Connectivity: None. Energy: None. Sterilization: EO (10^-6 SAL). Standards: ISO 594-1/-2 (connectors), ISO 6009:2016 (color coding), ISO 7864:2016 (cannula pull), ISO 9626:2001 (cannula stiffness/breakage).
Indications for Use
Indicated for adult and pediatric patients requiring administration of anesthesia or analgesia into the epidural space, placement of epidural catheters, or introduction of spinal needles for combined spinal-epidural procedures.
Regulatory Classification
Identification
An anesthesia conduction needle is a device used to inject local anesthetics into a patient to provide regional anesthesia.
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services logo on the left and the FDA logo on the right. The FDA logo features the letters 'FDA' in a blue square, followed by the words 'U.S. FOOD & DRUG' and 'ADMINISTRATION' in blue text.
July 1, 2022
Becton, Dickinson and Company Murtaza Rana Sr. Manager, Regulatory Affairs 1 Becton Drive Mc 237 Franklin Lakes, New Jersey 07417
Re: K211085
Trade/Device Name: BD Perisafe Tuohy Epidural Needle, BD Perisafe Weiss Epidural Needle Regulation Number: 21 CFR 868.5150 Regulation Name: Anesthesia Conduction Needle Regulatory Class: Class II Product Code: BSP Dated: May 27, 2022 Received: May 31, 2022
Dear Murtaza Rana:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies.combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition. FDA may publish further announcements concerning your device in the Federal Register.
{1}------------------------------------------------
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801 and Part 809); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531 -542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely.
Todd Courtney Assistant Director DHT1C: Division of Sleep Disordered Breathing, Respiratory and Anesthesia Devices OHT1: Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
# Indications for Use
510(k) Number (if known) K211085
#### Device Name
BD Perisafe™ Tuohy Epidural Needle BD Perisafe™ Weiss Epidural Needle
#### Indications for Use (Describe)
BD Perisafe™ Tuohy Epidural Needle and BD Perisafe™ Weiss Epidural Needle are indicated for the administration of anesthesia or analgesia into the epidural space, or to introduce a dedicated catheter for continuous administration of anesthesia or analgesia into the epidural space. They can also be used to introduce a spinal needle to perform a combined spinal and epidural procedure.
These devices are intended for adult and pediatric patients.
Type of Use (Select one or both, as applicable)
| <span> <svg height="16" width="16"> <rect fill="white" height="16" stroke="black" width="16"></rect> <path d="M2,2 L14,14 M14,2 L2,14" stroke="black"></path> </svg> Prescription Use (Part 21 CFR 801 Subpart D) </span> | <span> <svg height="16" width="16"> <rect fill="white" height="16" stroke="black" width="16"></rect> </svg> Over-The-Counter Use (21 CFR 801 Subpart C) </span> |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------|
### CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
{3}------------------------------------------------
Image /page/3/Picture/0 description: The image shows the BD logo. The logo consists of an orange circle with a white design inside, and the letters "BD" in blue. The design inside the circle looks like a stylized sun or flower.
# 510(k) Summary (21 CFR §807.92)
BD Perisafe™ Tuohy Epidural Needle BD Perisafe™ Weiss Epidural Needle
| Submitter<br>Information | Submitter Name:<br>Submitter Address:<br>Contact Person:<br>Email Address:<br>Phone Number:<br>Date of Preparation: | Becton, Dickinson and Company<br>1 Becton Drive<br>Franklin Lakes, NJ 07417<br>Murtaza Rana<br>Senior Regulatory Affairs Manager<br>murtaza.rana@bd.com<br>(201) 847-6980<br>May 27, 2022 | |
|--------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--|
| Subject Device | Trade Name:<br>Common Name:<br>Regulation Number:<br>Regulation Name:<br>Regulatory Class:<br>Product Code:<br>Classification Panel: | BD Perisafe™ Tuohy Epidural Needle<br>BD Perisafe™ Weiss Epidural Needle<br>Anesthesia Epidural Needle<br>21 CFR 868.5150<br>Anesthesia Conduction Needle<br>Class II device<br>BSP (Needle, Conduction, Anesthetic<br>(W/Wo Introducer))<br>Anesthesiology | |
| Predicate Device | Trade Name:<br>510(k) Reference:<br>Common Name:<br>Regulation Number:<br>Regulation Name:<br>Regulatory Class:<br>Product Code:<br>Classification Panel: | Epidural Anesthesia Needles, Spinal<br>Anesthesia Needles, Combined<br>Anesthesia Needles<br>K171518<br>Epidural Anesthesia Needles, Spinal<br>Anesthesia Needles, Combined<br>Anesthesia Needles<br>21 CFR 868.5150<br>Anesthesia Conduction Needle<br>Class II Device<br>BSP (Needle, Conduction, Anesthetic<br>(W/Wo Introducer))<br>Anesthesiology | |
| Reason for<br>Submission | The intent of this 510(k) submission is to establish a new 510(k)<br>baseline for the BD Perisafe™ Tuohy Epidural Needle and<br>BD Perisafe™ Weiss Epidural Needle. | | |
| Device Description | BD Perisafe™ Tuohy Epidural Needle and BD Perisafe™ Weiss<br>Epidural Needle are single use, sterile needles which incorporate<br>an ISO 594-1/-2 compliant connector. The needles are also<br>available in bulk, non-sterile configurations (to be sterilized prior<br>to use). | | |
{4}------------------------------------------------
| | Each type of needle consists of a hollow, stainless steel cannula,<br>a translucent, polypropylene hub and a polypropylene shield<br>over the needle. The cannula is bonded to the hub at one end.<br>The BD Perisafe™ Epidural needles also contain a plastic stylet<br>handle and are available in various needle lengths.<br>The needle hubs are ISO 594-1 and ISO 594-2 compliant<br>connectors. The stylet handle for the BD Perisafe™ Epidural<br>needles is color coded and correlate to the gauge size per ISO<br>6009:2016. |
|----------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications for Use | The BD Perisafe™ Tuohy Epidural Needle and BD Perisafe™<br>Weiss Epidural Needle are indicated for the administration of<br>anesthesia or analgesia into the epidural space, or to introduce<br>a dedicated catheter for continuous administration of anesthesia<br>or analgesia into the epidural space. They can also be used to<br>introduce a spinal needle to perform a combined spinal and<br>epidural procedure.<br>These devices are intended for adult and pediatric patients. |
| Technological<br>Characteristics | The subject devices are equivalent to the predicate devices in<br>intended use, materials and performance characteristics. |
{5}------------------------------------------------
| Element of<br>Comparison | Subject Device<br>(BD Perisafe™<br>Tuohy<br>Epidural Needle<br>BD Perisafe™ Weiss<br>Epidural Needle) | Predicate<br>Device<br>(Epidural<br>Anesthesia<br>Needles,<br>Zhejiang kindly<br>Medical<br>Devices,<br>K171518) | Substantial Equivalence |
|-------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications for Use | The BD Perisafe™<br>Tuohy Epidural<br>Needle and BD<br>Perisafe™ Weiss<br>Epidural Needle are<br>indicated for the<br>administration of<br>anesthesia or<br>analgesia into the<br>epidural space, or to<br>introduce a dedicated<br>catheter for<br>continuous<br>administration of<br>anesthesia or<br>analgesia into the<br>epidural space. They<br>can also be used to<br>introduce a spinal<br>needle to perform a<br>combined spinal and<br>epidural procedure.<br>These devices are<br>intended for adult and<br>pediatric patients. | The Epidural<br>Anesthesia<br>Needles are<br>intended to be<br>used for injection<br>into the epidural<br>space/or placing<br>the epidural<br>catheter into the<br>epidural space.<br>The Combined<br>Anesthesia<br>Needles are<br>intended for<br>injection of local<br>anesthetics into<br>the spinal and<br>epidural spaces of<br>a patient to<br>provide regional<br>anesthesia. The<br>administration of<br>the spinal<br>anesthesia allows<br>rapid anesthesia<br>onset and the<br>placement of an<br>epidural catheter<br>allows for bolus<br>injections or<br>continuous<br>infusion of local<br>anesthetics or<br>other drugs into<br>the epidural<br>space. | Substantially equivalent to<br>predicate device as both are<br>intended for administration of<br>anesthesia in epidural space<br>and for combined spinal and<br>epidural procedures. |
| Technological Characteristics | | | |
| Components | Stylet Handle<br>Stylet<br>Needle Tube<br>(Cannula)<br>Needle Hub<br>Protective Cap of<br>Needle (Shield) | Stylet Hub<br>Stylet<br>Needle Tube<br>Needle Hub<br>Needle Hub<br>Insert<br>Protective Cap of<br>Needle | Substantially equivalent. The<br>only difference is the absence of<br>a needle hub insert. This is<br>because the needle tube<br>(cannula) is insert molded to the<br>needle hub for the subject<br>device. |
| Needle Gauge | 16G - 20G | 14G - 22G | The proposed devices have |
| Needle Length | 50.8mm, 80mm,<br>88.9mm, 127mm | 65mm, 70mm,<br>80mm, 90mm,<br>100mm, 110mm,<br>120mm, 150mm | different combination of needle<br>gauge and needle length<br>compared with the predicate<br>device. However, the different<br>device configurations will be<br>selected by the physician per<br>patient's condition. Therefore,<br>this difference is not considered<br>to affect substantial<br>equivalence. |
| Needle Tip | Tuohy, Weiss | Tuohy | The Weiss needle tip geometry<br>is same as the Tuohy needle tip<br>geometry with the only<br>difference being the addition of<br>"wings" to the needle hub to<br>make it easier to grasp the<br>needle with both hands for<br>placement. This difference is<br>not considered to affect<br>substantial equivalence. |
| Sterile | EO Sterilized, 10-6 | EO Sterilized, 10-6 | Substantially equivalent. |
| Single Use | Single Use | Single Use | Substantially equivalent. |
| Labeling | Conform with 21 CFR<br>801 | Conform with 21<br>CFR 801 | Substantially equivalent. |
{6}------------------------------------------------
| Functional Testing: | | | |
|---------------------------------------------|-----------------------------------------------------|----------------------------|------------------------------|
| Fluid leakage by Pressure<br>Decay | Per ISO 594-1 and 594-2 | Per ISO 594-1<br>and 594-2 | Substantially<br>equivalent. |
| Subatmospheric pressure air<br>leakage | Per ISO 594-1 and 594-2 | Per ISO 594-1<br>and 594-2 | Substantially<br>equivalent. |
| Stress cracking | Per ISO 594-1 and 594-2 | Per ISO 594-1<br>and 594-2 | Substantially<br>equivalent. |
| Resistance to separation<br>from axial load | Per ISO 594-1 and 594-2 | Per ISO 594-1<br>and 594-2 | Substantially<br>equivalent. |
| Resistance to separation<br>from unscrewing | Per ISO 594-2 | Per ISO 594-2 | Substantially<br>equivalent. |
| Resistance to overriding | Per ISO 594-2 | Per ISO 594-2 | Substantially<br>equivalent. |
| Stylet Pull Force | Per internal requirements<br>(Must exhibit material | Not specified | Substantially<br>equivalent* |
{7}------------------------------------------------
| | stretch<br>with no separation at<br>stylet/handle junction) | | |
|------------------------------------------------------------|------------------------------------------------------------------------------------------------------|--------------------------------------|------------------------------|
| Handle/Hub Separation Force | Per internal requirements<br>(Handle must not disengage<br>when held upside down) | Not specified | Substantially<br>equivalent* |
| Needle Shield/Hub<br>Separation Force | Per internal requirements<br>(Needle shield must not<br>disengage from hub when<br>held upside down) | Not specified | Substantially<br>equivalent* |
| Cannula Pull Force (Bond<br>between hub and needle) | Per ISO 7864:2016 | Per ISO 7864:2016 | Substantially<br>equivalent. |
| Cannula deflection/ Stiffness | Per ISO 9626:2001 | Per ISO 9626:1991 | Substantially<br>equivalent. |
| Cannula breakage | Per ISO 9626:2001 | Per ISO 9626:1991 | Substantially<br>equivalent. |
| Biocompatibility Testing:<br>Testing per ISO 10993-1:2018: | | | |
| Cytotoxicity | Per ISO 10993-5:2009,<br>Non-cytotoxic | Per ISO 10993-5,<br>Non-cytotoxic | Substantially<br>equivalent. |
| Sensitization | Per ISO 10993-10:2010,<br>Non-sensitizer | Per ISO 10993-10, Non-<br>sensitizer | Substantially<br>equivalent. |
| Intracutaneous Reactivity | Per ISO 10993-10:2010,<br>Non-irritant | Per ISO 10993-10, Non-irritant | Substantially<br>equivalent. |
| Acute Systemic Toxicity | Per ISO 10993-11:2017,<br>Non-toxic | Per ISO 10993-11, Non-toxic | Substantially<br>equivalent. |
| Material-Mediated<br>Pyrogenicity | Per ISO 10993-11:2017 and<br>USP<151>, Non-pyrogenic | Not specified | N/A |
| Chemical Characterization | Per ISO 10993-18:2005,<br>acceptable<br>extractables/leachables | Not specified | N/A |
## Additional Testing:
| Hemolysis | Per ISO 10993-4:2017, Non-hemolytic | Per ISO 10993-4, Non-hemolytic | N/A |
|-----------------------------|-------------------------------------------------------------------------------------------------------------------------------|--------------------------------|-----|
| LAL Endotoxin | Per USP<85>,<br>2.15 EU/device | Not Specified | N/A |
| Particulate Matter | Per USP <788>, Met limits | Not Specified | N/A |
| Neurotoxicity<br>Assessment | No signs of systemic toxicity or<br>neurological impairment from<br>exposure of leachable compounds<br>from the test article. | N/A | N/A |
profile
* Although it is not clear if these tests were performed by the predicate device manufacturer and since there are differences in design and materials between the predicate and subject devices, BD performs additional testing as needed to address any potential risks identified. These internal tests help mitigate the following risks:
{8}------------------------------------------------
- Stylet Pull Force This test addresses the risk of the stylet wire potentially . separating from the stylet handle, resulting in user inconvenience and/or inability to use the product.
- . Handle/Hub Separation Force - This test addresses the potential of the stylet falling out from the needle hub, which can result in user inconvenience and/or inability to use the product.
- . Needle Shield / Hub Separation Force - This test addresses the potential of the shield coming off too easily from the needle hub which could result in user inconvenience or potential for needle-stick injury.
Therefore, BD believes that these additional tests are reguired to support the safety and effectiveness of the subject devices.
| Performance Tests | BD has performed the following non-clinical/design verification<br>testing/analysis and the results of these tests/analysis<br>demonstrate that the BD Perisafe™ Epidural Needles performed<br>in an equivalent manner to the predicate devices. | |
|-------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------|
| | Per ISO 594 | |
| | • | Fluid leakage by Pressure Decay |
| | • | Subatmospheric pressure air leakage |
| | | Stress Cracking |
| | • | Resistance to separation from axial load |
| | • | Resistance to separation from unscrewing |
| | • | Resistance to overriding |
| | • | Stylet Pull Force |
| | Per ISO 9626 | |
| | • | Cannula deflection/ Stiffness |
| | • | Cannula breakage |
| | Per BD internal requirements: | |
| | • | Stylet Pull Force |
| | • | Handle/Hub Separation Force |
| | • | Needle Shield/Hub Separation Force |
| | Per ISO 7864: | |
| | • | Cannula Pull Force (Bond between hub and needle) |
| | BD has performed the following Material Biocompatibility<br>Performance testing on the BD Perisafe™ Tuohy Epidural Needle<br>and BD Perisafe™ Weiss Epidural Needle. | |
{9}------------------------------------------------
| | Per ISO 10993-1:2018:<br>• Cytotoxicity<br>• Sensitization<br>• Intracutaneous Reactivity<br>• Acute Systemic Toxicity<br>• Material-Mediated Pyrogenicity<br>• Chemical Characterization<br><br>Additionally, the following tests were performed:<br>• Hemolysis<br>• LAL Endotoxin<br>• Particulate Matter<br><br>BD has performed the following Material Biocompatibility<br>Performance testing on the BD® Whitacre Spinal NRFit™ Needle<br>that was cleared under K193131. The same testing is being<br>leveraged for this submission, as the materials of the subject<br>device are the same as that of the BD® Spinal NRFit Needles.<br>• Neurotoxicity Assessment<br><br>The subject device continues to meet all the predetermined<br>acceptance criteria for the above-listed performance tests,<br>demonstrating substantial equivalence to the predicate device. |
|------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Clinical Testing | Clinical testing was not required for this submission |
| Summary of<br>Substantial<br>Equivalence | BD Perisafe™ Tuohy Epidural Needle and BD Perisafe™ Weiss<br>Epidural Needle are substantially equivalent to the predicate<br>devices in its intended use, principles of operation, technology,<br>design, materials and performance |
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.
Sort by:
Create Alert
Search Filters
Agent Token
Create a read-only bearer token for Claude, ChatGPT, or other agents that can call HTTP APIs.
Copy this now. It will not be shown again.
Connected apps
Apps you authorized through browser sign-in. Disconnecting revokes their access immediately.
Learn the FDA Browser
Two short videos show you everything — or skip straight to the written tutorial if you'd rather read. You can reopen this any time from the Tutorial button in the top bar.
Part 1 — Search, results, and everyday workflows 16 min
Part 2 — Embeddings: the galaxy map 3 min
1. Search: exact and fuzzy
Type a phrase like "coronary artery calcification" into the search box. You get two kinds of results. Exact results match the literal phrase — prefix searches work ("coronary artery calcificati") but suffix searches do not. Fuzzy results match on the meaning and intent of your phrase rather than the exact words, and are sorted by relevance score. Hover over the Exact or Fuzzy badge on any row to see exactly why it matched.
Use the checkboxes above the results to narrow: SaMD keeps only software-only devices, AI / ML keeps only devices with AI.
Exact vs. fuzzy search: what's the difference?
Exact matches on the literal phrase (prefix search works, suffix does not). Fuzzy matches on the meaning and intent of the phrase rather than the exact words. Hover over the badge on any row to see why it matched.
You search "coronary artery calcification" and want only software devices with AI. What two filters do you apply?
Narrow by SaMD (software-only devices), then narrow by AI/ML (devices with AI).
2. The results table
Scroll right in the results table. The intended use is extracted for you — no need to open the PDF. The device story gives a high-level snapshot of what the device does and how it's used. The AI Performance sub-table shows each output name, acceptance criteria, observed values, and development/test dataset descriptions — the same format Innolitics uses for regulatory strategy outputs, and the fastest high-level fingerprint of an AI device. It is AI-generated but has been very reliable in practice.
Where do you find a device's intended use without opening the PDF?
Scroll right in the search results table. The intended use column is extracted for you; no need to dig into the 510(k) summary PDF.
What does the AI Performance sub-table show, and why is it useful?
Output name, acceptance criteria, observed values, development dataset description, and test dataset description. It's the same format we use for regulatory strategy output and Fast 510(k) input, and the fastest high-level fingerprint of an AI device. AI-generated but reliable in practice.
3. Judging fuzzy relevance
Fuzzy results trail off in relevance as you scroll. Use three signals to decide how far down to go: the fuzzy badge explanations, the intended use column, and whether your target output (e.g., Cobb angle) still appears in the AI Performance sub-table. Once it stops appearing, you're past the relevant zone. A top hit with a low score (~0.4) and a stretched explanation is a hint the closest predicates are far away — the project may be headed for De Novo. Note the fuzzy search is a pattern match: it doesn't handle negation ("not") well, and hardware devices can appear — filter by SaMD/AI ML to cut them.
How do you judge how far down fuzzy search results to go?
Use the relevancy signals: the fuzzy badge explanations, the intended use column, and whether the target output (e.g., Cobb angle) still appears in the AI Performance sub-table. Once it stops appearing, results are trailing off in relevancy.
4. Device detail page: chat and citations
Click a device name to open its detail page: device facts on the left, a chat window on the right. Ask something like "Describe the training data". The answer carries little citation bubbles — click one to jump to the highlighted passage in the source PDF, so you can verify every AI answer against the document. There's also a Download PDF button for sharing.
How do you verify an AI chat answer on the device detail page?
Click the citation bubbles to jump to the relevant highlight in the source document.
Reading rule for every project: how many summaries do you read in full?
At least the three most relevant 510(k) or De Novo summaries, in full. After that, use targeted chat questions to confirm your memory quickly. The tool supports this professional habit — it doesn't replace it.
5. Side-by-side comparison
Select multiple rows in the results table (aim for under ~10), then open the PDF Viewer tab. Ask one question — it goes to all selected devices in parallel, each with citations. This is the fastest way to compare and contrast devices: training data, PCCP scope, how they handled adding new scanners, and so on.
What does the side-by-side PDF viewer mode do?
Select multiple devices, open the PDF viewer tab, and ask one question (e.g., "Describe the training data"). It queries all selected devices simultaneously with citations, so you can compare and contrast quickly.
6. Collections
With rows selected, go to the Collections tab and create a labeled collection (e.g., "Cobb Angle Project"). Reload that selection any time — before a client call, pull up the collection and ask questions across all of its devices at once.
How do you save a set of selected devices for later use?
Select the rows, go to the Collections tab, and create a labeled collection (e.g., "Cobb Angle Project"). You can reload the selection anytime and carry it into the PDF viewer and other tabs that support selections.
7. Product codes and the regulations tree
Click a product code in the results to jump to it in the regulations tree — identification text, sibling product codes, and devices you can open in a PDF viewer on the right. Click a regulation number to see its identification, special controls, and related product codes. You can also search by product code or regulation number at the top of the tree. Always read the special controls if any exist for your device — it broadens your search and sharpens pre-kickoff research.
What can you do from the regulations tree view?
Browse product codes and regulation numbers, read the identification text and special controls, browse sibling product codes, open device PDFs on the right, and search by product code or regulation number at the top of the tree.
8. Chart view
Click Show Chart and segment by regulation number (or product code) to see which regulations dominate your result set. Clicking a regulation takes you into the regulations tree. Great for spotting that most matches are, say, hardware laparoscopic devices — a cue to go back and filter.
How do you see which regulations dominate a search result set?
Click "Show Chart" and segment by Regulation Number. Clicking a regulation takes you to the regulations tree.
9. The predicate graph
Open the Predicates tab for a family-tree view of predicate relationships. Click a node to trace its parents and children; selections from search carry over pre-selected. Commonly predicated devices are worth reading — a lot of people predicated them for a reason. The visual lineage is also handy on client calls, e.g. to show how a predicate family evolved and justify why your predicate still holds.
In the predicate graph, why are commonly predicated devices worth reading?
A lot of people predicated them for a reason. Clicking a node traces parents and children, and selections from search carry over pre-selected.
10. Embeddings: the galaxy map
The Embeddings tab plots every matching document in a 2-D "galaxy map" where semantically similar devices cluster together. Hover or click clusters to explore, and let AI label the clusters for you. Embeddings beat product codes for grouping: two devices can carry different product codes (LLZ vs. QIH) yet do the same thing — the embedding captures the meaning of the intended use and device story. This is also exactly how retrieval-augmented generation (RAG) works under the hood, and it makes a great visual on client calls.
Try it yourself
Head to the search page and work through a few of these AI/ML fuzzy searches to build intuition: perivascular fat on CT · aortic valve calcification opportunistic screening on noncontrast CT · breast cancer prediction on digital pathology slides · autism detection · gestational age prediction · a hearing aid that can also detect a pulse · foundation model based analysis of ECG · large language models · penetration test. Watch how the relevance scores, intended use, and AI Performance tables tell you when results stop being meaningful.